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isolated from equine samples submitted
to a diagnostic laboratory
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Abstract
Background: Antimicrobial resistance limits traditional treatment options and increases costs. It is therefore
important to estimate the magnitude of the problem so as to provide empirical data to guide control efforts.
The aim of this study was to investigate the burden and patterns of antimicrobial resistance (AMR) among equine
Staphylococcus samples submitted to the University of Kentucky Veterinary Diagnostic Laboratory (UKVDL) from
1993 to 2009. Retrospective data of 1711 equine Staphylococcus samples submitted to the UKVDL during the time
period 1993 to 2009 were included in the study. Antimicrobial susceptibility testing, that included 16 drugs, were
performed using cultures followed by the Kirby-Bauer disk diffusion susceptibility test. The proportion of resistant
isolates by animal breed, species of organism, sample source, and time period were computed. Chi-square and
Cochran-Armitage trend tests were used to identify significant associations and temporal trends, respectively.
Logistic regression models were used to investigate predictors of AMR and multidrug resistance (MDR).
Results: A total of 66.3% of the isolates were resistant to at least one antimicrobial, most of which were
Staphylococcus aureus (77.1%), while 25.0% were MDR. The highest level of resistance was to penicillins (52.9%).
Among drug classes, isolates had the highest rate of AMR to at least one type of β-lactams (49.2%), followed by
aminoglycosides (30.2%). Significant (p < 0.05) associations were observed between odds of AMR and horse breed,
species of organism and year. Similarly, significant (p < 0.05) associations were identified between odds of MDR
and breed and age. While some isolates had resistance to up to 12 antimicrobials, AMR profiles featuring single
antimicrobials such as penicillin were more common than those with multiple antimicrobials.
Conclusion: Demographic factors were significant predictors of AMR and MDR. The fact that some isolates had
resistance to up to 12 of the 16 antimicrobials assessed is quite concerning. To address the high levels of AMR and
MDR observed in this study, future studies will need to focus on antimicrobial prescription practices and education of
both practitioners and animal owners on judicious use of antimicrobials to slow down the development of resistance.
Keywords: Staphylococcus, Antimicrobial resistance, Multidrug resistance, Horses, Equine, Kentucky, Burden, Predictors,
Logistic regression model
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Background
The development of antimicrobial agents has been one
of the most critical advances in both human and veterinary medicine within the last century. However, due to a
combination of factors, but most notably to the rise in
the use of antimicrobials for treating both human and
domestic species, antimicrobial resistance has become a
global scientific and public health concern in both human and veterinary medicine [1, 2]. The quantity of antimicrobials used in both human and veterinary medicine
as well as in aquaculture have contributed to the selection for antimicrobial resistance [3]. High rates of
antimicrobial resistant bacterial infections increase morbidity, be it to a single agent, or multiple drug classes,
hindering the ability to effectively treat infections. As a
result, both morbidity and mortality of antimicrobial resistant infections have increased in affected populations
[1]. Identification of the resistance profiles of microorganisms is a critical step in understanding antimicrobial
resistance and is useful in providing information to
guide treatment options and to combat the problem.
According to the World Health Organization, the frequency of resistance to first-line drugs that have traditionally been used to treat infections caused by
Staphylococcus has increased globally [4]. Unfortunately,
this resistance is not limited to human medicine, but is
being seen more frequently in domestic species, and in
equine medicine in particular [1]. Although the widespread use of antimicrobials among equine species in
the U.S. has been addressed in multiple forums, the epidemiology of antimicrobial resistance in bacteria found
in horses has not been assessed [2]. Identifying and describing the burden of antimicrobial resistance among
domestic species has become even more important due
to evidence of potential cross transmission of certain
bacteria between humans and domestic species [5]. Both
the Centers for Disease Control and Prevention (CDC)
and the United States Department of Agriculture
(USDA) have reported such findings in past years [6, 7].
Outcomes from these investigations found evidence of a
potential zoonotic transfer of Staphylococcus bacteria
and/or their genetic material between healthy humans
and horses [6, 8]. Other reports suggest that resistant
Staphylococcus infections in domestic animals may contribute to transmission seen in human contacts [9].
Understanding the burden of antimicrobial resistant
Staphylococcus infections in horses is critical in not only
being able to understand the risk to those in immediate
contact with these animals, but also in effectively providing information to guide efforts for the development of
antimicrobial stewardship programs. Although a number
of studies have investigated mainly methicillin-resistant
S. aureus in horses [10–14], many other Staphylococcus
species not only exhibit resistance to antimicrobials, but
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are clinically relevant to understanding the epidemiology
of antimicrobial resistance in horses and its zoonotic
spread to humans [2]. Thus, the objective of this study
was to estimate the proportion of antimicrobial resistant
staphylococcal isolates among equine samples submitted
to the University of Kentucky Veterinary Diagnostic
Laboratory between 1993 and 2009 and to identify
potential predictors of antimicrobial resistance and
multidrug resistance.

Methods
Data sources, preparation & study area

Laboratory records of all samples from horses submitted
to the University of Kentucky Veterinary Diagnostic
Laboratory were included in this study. The records
included a combination of antimicrobial sensitivity test results and animal demographic information. For the isolation of bacteria, specimens were cultured on blood agar
and eosin methylene blue agar plates at 37 °C in 5–10%
CO2, for a minimum of 24 h. If the specimen was from a
likely contaminated site such as nasal swab, a Columbia
colistin and nalidixic acid (CNA) plate with blood was also
inoculated. The plates were examined for pathogenic bacteria and were incubated for an additional 24 h at 37 °C in
aerobic incubators and examined again for pathogenic
bacteria. The criteria used for reporting a microorganism
was the isolation of the microorganism in pure culture or
significant numbers from specimens (as the predominate microorganism). Staphylococcus isolates were
identified by using colony morphology, dark-field
examination, β-hemolysis on blood agar and CNA
plates, and conventional biochemical tests, including
coagulase, catalase, maltose, mannitol, and trehalose.
Additionally, selective and differential plates with antimicrobials and indicator were used to differentiate
between S. aureus and S. hyicus.
Antimicrobial susceptibility testing, that included 16
drugs, were performed using Kirby-Bauer disk diffusion
susceptibility test. The laboratory followed procedures of
the Clinical Laboratory Standards Institute (CLSI) testing and classification to determine the susceptibility of
isolates [15–19]. Sizes of the zones of inhibition were
measured and interpreted as susceptible, intermediate,
or resistant. Sizes of zones of susceptible and resistant in
millimeters were as follows: bacitracin (≥ 13, ≤ 8), cephalothin (≥ 18, ≤ 14), erythromycin (≥21, ≤15), neomycin
(≥ 17, ≤ 12), kanamycin (≥ 18, ≤ 13), streptomycin (≥ 15,
≤ 11), oxacillin (≥ 13, ≤ 10), lincomycin (≥ 19, ≤ 15),
enrofloxacin (≥ 21, ≤ 17), amoxicillin/clavulanic acid
(≥ 20, ≤ 19), nitrofurantoin (≥17, ≤14), gentamicin
(≥ 15, ≤ 12), novobiocin (≥ 17, ≤ 14) penicillin (≥ 28,
≤ 19), tetracycline (≥ 23, ≤ 18), and trimethoprim
and sulfamethoxazole (≥ 16, ≤ 10). Isolates were
classified as either susceptible, intermediate or
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resistant based on the above classification procedure
[15–19]. For the purpose of this study, only susceptible and resistant isolates were included for subsequent analyses. Only records from the state of
Kentucky were included in the study.
Data analysis

All statistical analyses were performed in SAS 9.4 [20].
For the purpose of this study, the resistance status variable was reclassified into a binary outcome, resistant or
susceptible. Thus, all isolates indicated as “intermediate”
were not included in the analysis. Antimicrobial resistance (AMR) was defined as resistance to at least one
antimicrobial. Additionally, multi-drug resistance (MDR)
was defined as resistance to three or more antimicrobial
classes [21]. The proportion of resistant isolates and 95%
confidence intervals were computed by breed, sex, age,
sample source, the species of Staphylococcus, antimicrobial agent, year (which was scaled by subtracting 1993
from each year), season and month. Season was classified as follows: summer (June–August), fall (September–
November), winter (December–February), and spring
(March–May). All specimen types that had frequencies
of less than 1% were combined into a category called
“Other”. These were too many to list. Similarly, breeds
with frequencies less than 1% were classified as “other
breeds” and included Appaloosa, Belgian, Burro,
Clydesdale, Donkey, Draft, French Warmblood, Hanover,
Miniature Horse, Missouri Fox Trotter, Morgan, Other,
Paint, Palomino, Percheron, and Pony.
Temporal graphs were generated in excel to visualize
the temporal patterns of resistance. In addition, the
Cochran-Armitage Trend test was used to identify
significant temporal trends. Simple and multivariable
logistic regression models were used to investigate if
AMR had significant associations with breed, sex, age,
sample source, species of Staphylococcus organism, year,
season, and month. The model building process was
done in two steps. In the first step, simple logistic regression models were fitted with “AMR, (1 = Resistant, 0
= Susceptible)” as the outcome and each of the variables
in Table 1 as the explanatory variables. Variables with
p-values less than 0.15 were considered for inclusion
in the multivariable logistic regression model that was
used in the second step. During this 2nd step, the
multivariable logistic regression model was fitted
using a manual backwards selection procedure.
Confounding was assessed by comparing the change
in parameter estimate of the variables in the model
with and without the suspected confounding variable.
A 20% change in the estimate of any of the variables
already in the model was considered to be indicative
of a confounder that was then retained in the final
model. Odds ratios and their corresponding 95%
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confidence intervals were computed for all variables included in the final model. Goodness-of-fit of the final
model was assessed using the Hosmer-Lemeshow
goodness-of-fit test. No evidence of lack of fit was found.
Steps 1 and 2 for the process above were repeated to investigate predictors of multidrug resistance (MDR). In this
model, the outcome variable used was “MDR, (1 = Multidrug Resistant/0 = Not Multidrug Resistant)”. Again,
Goodness-of-fit of the final model was assessed using the
Hosmer-Lemeshow goodness-of-fit test. No evidence of
lack of fit was found.

Results
Summary statistics

A total of 1711 samples, from 26 horse breeds, were included in the study. The most common breeds were
Thoroughbreds (74.3%) followed by Tennessee Walking
Horses (5.6%) (Table 1). Overall, more samples were
submitted from female horses (83.7%) than male horses
(16.3%) (Table 1). Similarly, horses > 4 years old contributed the highest proportion of samples (46.0%), followed
by aborted fetuses (22.6%) and those < 1 year old (19.7%)
(Table 1). Additionally, samples testing positive for
coagulase negative Staphylococcus were most frequent
(47.8%), followed by coagulase positive Staphylococcus
aureus (40.3%). S. hyicus was the least frequent (4.4%).
Overall, 66.3% of the isolates were resistant to at least
one antimicrobial. Of the samples with known breed information, the highest proportion of resistant isolates was
from Thoroughbreds (70.5%) followed by the Standardbreds (68.6%) and Arabians (68.4%), while the lowest proportion of resistance was seen in mixed breeds (40.0%)
(Table 1). Standardbreds had the highest proportion of
MDR isolates (37.1%), followed by Thoroughbreds
(31.1%), and Quarter Horse (18.3%). The lowest proportion of MDR was in the Tennessee Walking Horse (3.4%)
(Table 1). Although females seemed to have a slightly
higher level of AMR (68.1%) than males (64.0%), these differences were not statistically significant. However, the
same does not apply to the levels of MDR between the
sexes. In fact, males had a markedly higher proportion of
MDR (32.9%) than females (25.4%) (Table 1).
Foals (< 1 years old) showed the highest levels of AMR
(75.9%), followed by horses 2–4 years old (67.3%), and
yearlings (1–2 years old) (65.6%). Adult horses (> 4 years
old) had the lowest levels of antimicrobial resistance
(60.0%) (Table 1). Foals again showed the highest levels
of MDR (37.6%) when compared with other age groups
(Table 1). MDR for horses 2–4 years old (28.9%) and
those 1–2 years old (18.8%) were again the next highest.
The highest proportion of AMR was observed among
Staphylococcus aureus isolates (77.1%) followed by
coagulase negative Staphylococcus strains (60.1%)
(Table 1). Similarly, Staphylococcus aureus (38.3%) again
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Table 1 Distribution and antimicrobial resistance of equine Staphylococcus samples submitted to the University of Kentucky
veterinary diagnostic laboratory, 1993–2009
Variable

95% CIa
No. of samples Percentage of
e
tested
samples tested (%)

AMRb samples AMRb, f (%) 95% CIa

Breed

n = 1577

n = 1046

MDRc samples MDRc,

g

(%) 95% CIa

Arabian

19

1.2

0.7, 1.7

13

68.4

43.5, 87.4 4

21.1

6.1, 45.6

American
Saddlebred

63

4.0

3.0, 5.0

34

54.0

40.9, 66.6 10

15.9

7.9, 27.3

Mixed breed

30

1.9

1.2, 2.6

12

40.0

22.7, 59.4 3

10.0

2.1, 26.5

Quarter horse

60

3.8

2.9, 4.8

28

46.7

33.8, 60.0 11

18.3

9.5, 30.4

Rocky Mountain
Saddlebred

16

1.0

0.5, 1.5

7

43.8

19.8, 70.1 1

6.3

0.2, 30.2

Standardbred

35

2.2

1.6, 3.1

24

68.6

50.7, 83.2 13

37.1

21.5, 55.1

Thoroughbred

1172

74.3

72.2, 76.5 826

70.5

67.8, 73.1 365

31.1

28.5, 33.9

Tennessee
Walking Horse

88

5.6

4.5, 6.7

46

52.3

41.4, 63.0 3

3.4

8.5, 75.5

Other breeds

94

6.0

4.8, 7.3

56

59.6

49.0, 69.6 9

9.6

4.5, 17.4

1152

83.7

81.6, 85.6 784

68.1

65.3, 70.7 293

25.4

22.9, 28.1

225

16.3

14.4, 18.4 144

64.0

57.4, 70.3 74

32.9

26.6, 39.5

Sex

n = 1377

Female
Male
Age Groups

n = 928

n = 717

n = 459

> 4 years

330

46.0

42.4, 49.7 198

60.0

54.5, 65.3 68

34.3

16.4, 25.4

2–4 years

52

7.3

5.5, 9.4

35

67.3

52.9, 79.7 15

28.9

17.1, 43.1

1–2 years

32

4.5

3.0, 6.0

21

65.6

46.8, 81.4 6

18.8

7.2, 36.4

< 1 year

141

19.7

16.8, 22.6 107

75.9

68.0, 82.7 53

37.6

29.6, 46.1

Aborted fetus
(0 years)

162

22.6

19.5, 25.7 98

60.5

52.5, 68.1 35

21.6

15.5, 28.8

Species of organism n = 1711
d

n = 1131

CoNS

817

47.8

45.4, 50.1 491

60.1

56.7, 63.5 163

20.0

17.3, 22.9

Staphylococcus
aureus

689

40.3

37.9, 42.6 531

77.1

73.7, 80.2 264

38.3

34.7, 42.1

Staphylococcus
hyicus

75

4.4

3.4, 5.4

31

41.3

30.1, 53.3 1

1.3

0.03, 7.2

Staphylococcus
intermedius

130

7.6

6.3, 8.9

78

60.0

51.1, 68.5 16

12.3

7.2, 19.2

a

95% Confidence Interval
AMR: Antimicrobial Resistance
c
MDR: Multidrug Resistance
d
Coagulase negative Staphylococcus
e
The denominators are the number of samples tested for each variable and vary (e.g. breed = 1577; sex = 1377; etc) due to missing data
f
The denominators for the percentage of AMR are the number of samples tested per row
g
The denominators for the percentage of MDR are the number of samples tested per row
b

had the highest levels of MDR, followed by coagulase
negative Staphylococcus strains (20.0%) (Table 1).
Distribution of resistance across antimicrobials

Overall, 16 antimicrobials from 10 antimicrobial classes
were examined in this study (Table 2). Highest proportions of AMR isolates were seen among β-lactams
(49.2%), with more isolates exhibiting resistance to
Penicillin (52.9%) than oxacillin (15.6%) (Table 2 and
Fig. 1). The drug class with the second highest proportion of AMR isolates was aminoglycosides (30.2%)

(Fig. 1), with 28.9% and 22.8% of the isolates exhibiting
resistance to Kanamycin and Gentamicin, respectively
(Table 2). As for MDR, β-Lactams again had the highest
levels (23.5%) of isolates that were MDR followed by
Aminoglycosides (22.1%) (Table 2 and Fig. 1). Although
the majority of resistant isolates (51.3%) were only resistant to 1 or 2 antimicrobial classes, 13.4% of the resistant
isolates were resistant to 5 antimicrobial classes.
Of the isolates that were found to be MDR, 8.0% were
resistant to 9 antimicrobials (Amoxycillin/clavulanic
acid, Erythromicin, Gentamicin, Kanamycin, Oxacillin
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Table 2 Distribution of antimicrobial resistance categorized by antimicrobial class among equine Staphylococcus samples submitted
to the University of Kentucky veterinary diagnostic laboratory, 1993–2009
Antimicrobial class

Drug

Aminoglycosides

AMRa samples

AMRa %

95% CIb

MDRc samples

MDRc %

95%CIb

516/1710

30.2

28.0, 32.4

377/1710

22.1

20.1, 24.1

Neomycin

53/1582

3.4

2.5, 4.4

46/1582

2.9

2.1, 3.9

Kanamycin

486/1682

28.9

26.7, 31.1

369/1682

21.9

20.0, 24.0

Streptomycin

59/287

20.6

16.0, 25.7

28/287

9.8

6.6, 13.8

Gentamicin

369/1622

22.8

20.7, 24.9

270/1622

16.7

14.9, 18.6

841/1710

49.2

46.8, 51.6

402/1710

23.5

21.5, 25.6

Penicillin

814/1539

52.9

50.4, 55.4

396/1539

25.7

23.6, 28.0

Oxacillin

254/1634

15.6

13.8, 17.4

235/1634

14.4

12.7, 16.2

Amoxicillin/Clavulanic Acid

115/1644

7.0

5.8, 8.3

107/1644

6.5

5.4, 7.8

292/1668

17.5

15.7, 19.4

249/1668

14.9

13.3, 16.7

292/1668

17.5

15.7, 19.4

249/1668

14.9

13.3, 16.7

463/1645

28.2

26.0, 30.4

372/1645

22.6

20.6, 24.7

Sulfonamide

488/1702

28.7

26.5, 30.9

372/1702

21.9

19.9, 24.0

Trimethoprim-sulfadiazine

330/1355

24.4

22.1, 26.7

297/1355

21.9

19.7, 24.2

28/970

2.9

1.9, 4.2

25/970

2.6

1.7, 3.8

Lincomycin

28/970

2.9

1.9, 4.2

25/970

2.6

1.7, 3.8

141/1578

8.9

7.6, 10.6

31/1578

2.0

1.3, 2.8

141/1578

8.9

7.6, 10.6

31/1578

2.0

1.3, 2.8

β-lactams

Macrolides
Erythromycin
Sulfonamides

Lincosamides

Aminocoumarins
Novobiocin
Cephalosporins

63/1711

3.7

2.8, 4.7

63/1711

3.7

2.8, 17.1

Cephalothin

48/1692

2.8

2.1, 3.7

48/1692

2.8

2.1, 3.7

1/25

4.0

0.1, 20.4

1/25

4.0

0.1, 20.4

Enrofloxacin

1/24

4.2

0.1, 21.1

1/24

4.2

0.1, 21.1

451/1682

26.8

24.7, 29.0

326/1682

19.4

17.5, 21.4

451/1682

26.8

24.7, 29.0

326/1682

19.4

17.5, 21.4

45/1649

2.7

2.0, 3.6

36/1649

2.2

1.5, 3.0

45/1649

2.7

2.0, 3.6

36/1649

2.2

1.5, 3.0

Fluoroquinolones

Tetracyclines
Tetracycline
Polypeptides
Bacitracin
a

AMR: Antimicrobial Resistance
b
95% Confidence Interval
c
MDR: Multidrug Resistance

(Methicillin), Penicillin, Sulfonamides, Tetracycline, and
Trimethoprim-sulfadiazine) belonging to 5 antimicrobial
classes (Aminoglycosides, β-Lactams, Macrolides,
Sulfonamides and Tetracyclines) (Table 3). Another 7.0%
were resistant to the same profile of antimicrobials except Erythromycin. In fact, 46.0% of the isolates that
were MDR, and had a sample size greater than 10, had
resistance profiles that contained penicillin, kanamycin,
sulfonamides, and trimethoprim-sulfadiazine (Table 3).
Additionally, 34.0% of the MDR samples with sample sizes
greater than 10 showed resistance to oxacillin (Table 3).
Temporal trends

There was a significant (p = 0.023) decreasing temporal
trend in AMR over the study period (Fig. 2). The proportions of AMR isolates were highest in 2000 (76.0%)

and reached their lowest levels by 2007 (52.4%) (Fig. 2).
On the contrary, there was an increasing temporal trend
in MDR (p = 0.007) over the study period (Fig. 2). The
proportion of MDR isolates began at its lowest point in
1993 (14.4%) before reaching the highest level in 2000
(42.5%) (Fig. 2).

Predictors of antimicrobial resistance (AMR) and multidrug
resistance (MDR)

Species of organism, breed, age, sex, season, and year all
had significant simple associations with the odds of
AMR at an α = 0.15. (Table 4). Similarly, species of organism, breed, age, sex, and year had significant simple
associations with the odds of MDR (Table 4). All variables found to be significant (p ≤ 0.15) in the AMR or
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Fig. 1 Antimicrobial resistance and multidrug resistance by drug class from equine Staphylococcus samples submitted to the University of
Kentucky veterinary diagnostic laboratory, 1993–2009

MDR simple models were considered for inclusion in
their respective multivariable models.
Breed (p = < 0.001), species of organism (p = < 0.001)
and year (p = 0.023) were significantly associated with
the odds of antimicrobial resistant Staphylococcus
infections in horses (Table 5). There was a significant
(p = < 0.001) association between breed and AMR with
Thoroughbreds having higher odds (Odds Ratio [OR] =
1.61; 95% Confidence Interval [CI] = 1.07, 2.42) of AMR
than other breeds (Table 5). Interestingly, species of

organism was a significant predictor for AMR but not
MDR. The odds of AMR among Staphylococcus aureus
isolates was significantly (p < 0.0001) higher (OR = 2.30;
95% CI = 1.81, 2.93) than that of coagulase negative
Staphylococcus isolates (Table 5), while the odds of
AMR among Staphylococcus hyicus isolates was significantly (p < 0.0001) lower (OR = 0.46; 95% CI = 0.27,
0.77) than that of coagulase negative Staphylococcus
isolates. Year had a negative association with AMR
(OR = 0.97, 95% CI = 0.95, 1.00).

Table 3 Antimicrobial resistance profiles of equine resistant Staphylococcus samples submitted to the University of Kentucky
veterinary diagnostic laboratory, 1993–2009
Profile

No. of samples

Percent

95% CIa

Amo-Cep-Ery-Gen-Kan-Oxa-Pen-Sul-Tet-Tri

14

4.3

2.3, 6.9

Amo-Ery-Gen-Kan-Oxa-Pen-Sul-Tet-Tri

28

8.3

5.6, 11.8

Amo-Ery-Kan-Oxa-Pen-Sul-Tet-Tri

10

3.0

1.4, 5.4

Amo-Gen-Kan-Oxa-Pen-Sul-Tet-Tri

10

3.0

1.4, 5.4

Ery-Gen-Kan-Oxa-Pen-Sul-Tet-Tri

25

7.4

4.9, 10.8

Ery-Gen-Kan-Pen-Sul-Tet-Tri

14

4.2

2.3, 6.9

Ery-Kan-Oxa-Pen-Sul-Tet-Tri

12

3.6

1.9, 6.1

Gen-Kan-Oxa-Pen-Sul-Tet-Tri

17

5.0

3.0, 8.0

Gen-Kan-Pen-Sul-Tet-Tri

16

4.8

2.7, 7.6

Gen-Kan-Pen-Sul-Tri

10

3.0

1.4, 5.4

The denominator used for each percentage was (337) after missing values were removed
Amo Amoxiillin/clavulanic acid, Cep Cephalothin, Ery Erythromycin, Gen Gentamicin, Kan Kanamycin, Oxa Oxacillin, Pen Penicillin, Sul Sulfonamide, Tet Tetracycline,
Tri Trimethoprim-sulfadiazine
a
95% Confidence Interval
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Fig. 2 Annual temporal distribution of antimicrobial resistance & multidrug resistance from equine Staphylococcus samples submitted to the
University of Kentucky veterinary diagnostic laboratory, 1993–2009

Breed (p = < 0.001) and age (p = 0.020) were significantly associated with the odds of MDR of Staphylococcus (Table 6). The odds of isolates from Standardbreds
being MDR were over 15 times (OR = 15.0; 95% CI = 3.7,
60.4) higher than those of isolates from other breeds,
while the odds of MDR in isolates from Thoroughbreds
were almost 7 times (OR = 7.0; 95% CI = 2.4, 19.8) higher
than that of isolates from other breeds (Table 6). The
odds of MDR among isolates taken from foals (< 1 year)
were 63% (OR = 1.6; 95% CI = 1.0, 2.6) higher than that
of horses > 4 years old (Table 6).

Discussion
This study was designed to investigate the burden and
patterns of both AMR and MDR among equine
Staphylococcus samples submitted to the University of
Kentucky Veterinary Diagnostic Laboratory and to
Table 5 Significant predictors of antimicrobial resistant
Staphylococcus in equines from samples submitted to the
Kentucky state diagnostic laboratory, 1993–2009
Variable

AMRa P-Value

MDRb P-Value

Breed

< 0.001

< 0.001

Age

0.019

0.002

Organism

< 0.001

< 0.001

Sex

0.107

0.021

Season

0.083

0.781

Month

0.379

0.519

Year

0.046

0.001

City

0.390

0.146

P-Value
< 0.001

Arabian

1.5

0.5, 4.3

0.331

American Saddlebred

0.9

0.5, 1.7

0.763

Mixed Equine

0.5

0.2, 1.2

0.057

Quarter Horse

0.6

0.3, 1.2

0.091

Standard Bred

1.5

0.6, 3.3

0.245

Thoroughbred

1.6

1.1, 2.4

<.001

Tennessee Walking Horse

0.8

0.5, 1.5

0.397

Other Breeds

.

.

.

Staphylococcus aureus

2.3

1.8, 2.9

<.001

Staphylococcus hyicus

0.5

0.3, 0.8

<.001

Staphylococcus intermedius

1.1

0.7, 1.8

0.692

Coagulase negative Staphylococcus

.

.

.

0.97

0.95, 1.00

0.023

Species of Organism

a

Year

b

a

Antimicrobial Resistance
Multidrug Resistance

95% CIa

Breed

Table 4 Results of simple logistic models assessing predictors
of antimicrobial resistance and multidrug resistance in equine
Staphylococcus samples submitted to the Kentucky state
diagnostic laboratory, 1993–2009
Variable

Odds ratio

95% Confidence Interval

< 0.001
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could have a negative impact on morbidity and mortality
rates attributable to MDR infections [23, 24].

Table 6 Significant predictors of multidrug resistant
Staphylococcus in equines from samples submitted to the
Kentucky state diagnostic laboratory, 1993–2009
Variable

Odds ratio

95% CIa

Breed

P-value

Antimicrobials

< 0.001

There is a paucity of published literature on antimicrobial resistance in equine Staphylococcus infections. Most
of the work that has been published has focused only on
S. aureus and especially MRSA. Thus the lack of literature addressing resistant Staphylococcus species in
horses makes comparisons between the findings of this
study and others difficult. Suffice it to say that although
the overall proportions of AMR isolates in this study
were high, MRSA levels were much lower (15.6%) than
the percentage of MRSA (48%) found in a similar study
done in Turkey [25]. A Belgian study, by Van den Eede
et al., that assessed occurrence of MRSA in equine nasal
samples found similar MRSA levels (10.9%) to those
found in our study [26]. However, studies done in
Australia, Canada, and Ireland that investigated
Staphylococcus aureus colonization in healthy horses as
well as isolation rates in horses with clinical presentation
of MRSA found the percentage of AMR isolates to be
much lower and ranging from 4% to 8% [27–29]. These
differences could be attributed to the fact that we examined a higher number of antimicrobials and species of
Staphylococcus in this study in comparison with the
above studies that only investigated methicillin resistance in S. aureus.
The highest levels of resistance in this study was towards β-Lactams and Aminoglycosides. This may be due
to the tendency of staphylococci to adapt to the selection pressure of antimicrobial use and become resistant
to antimicrobials in general and the multiple mechanisms of resistance to aminoglycosides and β-Lactams in
particular [30, 31]. These findings are comparable to
those of a Swiss study which reported high levels of
AMR not only to β-lactams and aminoglycosides, but to
tetracyclines, lincosamides and macrolides as well when
compared to other drug classes [32]. We also found the
highest levels of AMR to be against penicillin (52.9%).
Much higher levels of resistance were reported from
equine hospital data in Zurich, where researchers identified AMR to penicillin in both coagulase negative
staphylococci and Staphylococcus aureus to be around
82% and AMR to tetracycline to be 64% [14]. High levels
of resistance to both penicillin (62.7%) and tetracycline
(23.7%) were found in a retrospective study in France
that investigated Staphylococci implicated in death or
euthanasia in horses [33]. The higher levels of AMR
Staphylococcus infections reported in hospitals could
explain the higher AMR levels from the Zurich study.
A German study looking at resistance profiles of
MRSA in horses from veterinary hospitals and large animal clinics found that gentamicin resistance was high

Arabian

3.9

0.6, 25.1

0.159

American Saddlebred

2.5

0.5, 12.5

0.257

Mixed Equine

2.3

0.5, 11.5

0.308

Quarter Horse

2.2

0.5, 8.7

0.277

Standardbred

15.0

3.7, 60.4

0.001

Thoroughbred

7.0

2.4, 19.8

0.000

Tennessee Walking Horse

0.8

0.2, 3.6

0.730

Other

.

.

.

Aborted Fetus 0 years

0.7

0.4, 1.2

0.171

Age

0.020

< 1 year

1.6

1.0, 2.6

0.042

1–2 years

1.8

0.6, 4.9

0.266

2–4 years

1.5

0.7, 3.1

0.275

> 4 years

.

.

.

a

95% Confidence Interval

investigate the predictors of AMR and MDR. The findings should provide information to guide future studies
and ongoing surveillance of antimicrobial resistance.
The proportion of antimicrobial resistant isolates seen in
this study for both coagulase negative Staphylococcus infections (60.1%) and coagulase positive strains including
S. aureus (77.1%), S. intermedius (60.0%), and S. hyicus
(41.3%) suggest that the levels of AMR are high for both
pathogenic and non-pathogenic Staphylococcus species.
Temporal trends

The temporal patterns observed in this study are interesting as a significant decreasing temporal trend was
found for AMR, while an increasing temporal trend was
observed for MDR. The reasons for this are unclear.
However, a University of California (U.C.), Davis study
that examined temporal trends in antimicrobial susceptibility patterns in equine case records from the William
R. Pritchard Veterinary Medical Teaching Hospital
(VMTH) from 1979 to 2010, found statistically significant increases over time in the percentage of Staphylococcus isolates susceptible to certain antimicrobials
(chloramphenicol, ceftiofur, and penicillin) [22]. It is
worth noting that, the U.C. Davis study investigated
multiple organisms (Pseudomonas species, Enterococcus
species, E. coli, Salmonella species., Streptococcus species, Staphylococcus species and Actinobacillus species)
while our study was limited to Staphylococcus species.
Findings from this study suggest that despite the significant decreasing AMR temporal trends, significant
increasing MDR temporal trends in this population
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(85%) and mainly associated with isolates coming from
equine clinics, while the majority of the isolates from all
horses in the study were resistant to tetracycline (97.5%)
and fluoroquinolones (79%) with only 15.6% being
resistant to erythromycin [34]. Our study found much
lower levels of AMR to gentamicin (22.8%), tetracycline
(26.8%) and fluoroquinolones (4.0%), than the German
study. Despite our MDR profiles containing gentamicin
(16.7%) and tetracycline (19.4%) resistance, these levels
were still not consistent with the findings of the German
study. The differences in the levels of AMR and MDR seen
in our study can be explained by the fact that the isolates
from our study included multiple Staphylococcus species.
Of the resistant isolates in this study, 25% were MDR.
This is double the percentage of MDR (13%) found in a
Lithuanian study by Klimienė et al. [35] and a Zurich
study [14] that both reported 13% MDR. However, it is
more than double that reported by Toombs-Ruane et al.
(10.1%) in New Zealand [36]. The Swiss study mentioned previously, also found that isolates were most
likely to be MDR involving β-lactams, aminoglycosides,
and tetracyclines [32]. That finding is similar to that of
our study where the highest proportion of MDR infections involved aminoglycosides, β-lactams, sulfonamides,
cephalosporins and tetracyclines. Interestingly, a recent
companion animal study done in India found that not
only were the incidences of Staphylococcus aureus
wound infections higher in equines (57.14%), but that
there was 100% MDR against kanamycin, colistin, clindamycin, penicillin-G, cotrimoxazole and cefotaxime
[37]. However, it is worth noting that the current study
only focused on Staphylococcus infections in horses and
not multiple companion animals as was the case in the
Indian study.
Antimicrobial resistance profile

Almost half of the MDR isolates in this study had antimicrobial resistance profiles that included penicillin, kanamycin, sulfonamides, and trimethoprim-sulfadiazine.
These findings are consistent with those of a similar study
that found that, in isolates identified to be MDR,
Staphylococcus isolates that were oxacillin resistant, were
also resistant to kanamycin, gentamicin and penicillin
[38]. In our study less than 1% of the isolates were resistant to 12 antimicrobials and antimicrobial resistance profiles showed MDR to occur most frequently among
isolates resistant to aminoglycosides, β-lactams, tetracyclines, sulfonamides, and cephalosporins. These findings
were different from those of a study done in Switzerland
by Schnelleman et al., [32], where 24% of the Staphylococcus isolates were resistant to all 12 of the antimicrobials
tested, while the remainder of the isolates were resistant
to a number of drug classes including β-lactams, combination β-lactam-β-lactamase-inhibitors, aminoglycosides,
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tetracyclines, chloramphenicol, macrolides, lincosamides
and/or streptogramins [32]. It is important to note that
isolates from the Swiss study were obtained only from
horses undergoing colic surgery. A Lithuanian study by
Klimienė et al. [35], found that the Staphylococcus isolates
that were MDR showed high levels of resistance to penicillin G, erythromycin or tetracycline. Similar to the findings of our study, they reported that 66.7% of the isolates
showed resistances to penicillin, erythromycin, tetracycline, ciprofloxacin, and gentamicin.
Distribution of resistance by host factors, species of
organism and time

Thoroughbreds had the highest proportion of antimicrobial resistance (70.5%) in this study. This number is strikingly higher than the 5% AMR levels found in a similar
study in Japan that examined MRSA colonization and infection in thoroughbreds [12]. However, because the
Japanese study only looked at MRSA in thoroughbreds,
while our study was able to examine both AMR and MDR
in thoroughbreds, it is difficult to make direct comparisons between the AMR levels of the two. Nonetheless, a
Canadian study looked at a mixture of draft, race, pleasure, breeding, school, and show horses and found no evidence of MRSA in thoroughbreds [29]. In this study, we
found that the odds of AMR in thoroughbreds was higher
than that of other breeds. The higher odds of AMR in
thoroughbreds could be due to the extensive movement
of this particular horse breed, increasing the risk for exposure to resistant Staphylococcus strains and contributing
to higher resistance levels. Another Canadian study hypothesized that frequent contact with other horses, recurring and frequent travel to different sites, and the frequent
use of antimicrobials in this set of horses could be associated with increased prevalence of MRSA in show and race
horses [39]. Race horses, especially thoroughbreds, are
moved frequently between Canada and the United States
due to the large racing industry in both countries, which
makes the risk of MRSA colonization and infection more
widespread than seen in other breeds [40]. Horses, and
thoroughbreds, in particular, are often moved between the
United States, Australia, Canada, Japan, the UK, and
Ireland, increasing the risk of importing infected carrier
horses [12]. This could explain the high levels of resistance
seen in thoroughbreds in this study.
A significant simple association was found between
age and the odds of both AMR and MDR in this study.
However, a significant association was only found
between MDR and age in the multivariable model with
age group less than 1 year showing significantly higher
odds of MDR. Many past studies have focused on foals
as an important population for studies of antimicrobial
susceptibility [22, 41–44]. This is likely due to the higher
susceptibility of younger animals to infection resulting in
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higher likelihood of antimicrobial treatment and hence
selection for resistance. In this study Staphylococcus
aureus was found to have significantly higher odds of
AMR when compared with other Staphylococcus species,
which is likely due to adaptability seen in S. aureus, [45],
as well as the high prevalence of methicillin resistance in
Staphylococcus aureus isolates, which indicates intrinsic
resistance to all other β-Lactams, aminoglycosides and
macrolides [46, 47].
Year was a significant predictor of AMR but not MDR
in this study, where the odds of AMR isolates decreased
over time. Decreases in AMR are likely due to changes
in surveillance and reporting practices for resistant
Staphylococcus infections, as well as adherence to sound
antimicrobial prescription practices and policies. A study
by Weese & Rousseau [48] found that after implementation of both active surveillance cultures and infection
control procedures to address endemic MRSA, there
was a rapid decrease in the proportion of horses
colonized with MRSA. The study done by Weese &
Rousseau focused on MRSA infections so direct comparisons cannot be made. However, it does indicate that appropriate control measures can affect the proportion of
resistance infections observed and reported.

Study limitations
This retrospective laboratory-based study is not without
limitations. Since data were not obtained using a statistical sampling technique, the study population should
not be considered to be representative of the equine
population in Kentucky. Only data available in the laboratory records could be investigated limiting the scope
of investigation. For instance, information on past antimicrobial use was not available and therefore we could
not assess its associations with levels of AMR or MDR.
Furthermore, past medical history of the animals whose
samples were used in this study was not reported.
Conclusion
The above limitations notwithstanding, the findings of
this study provide useful information on the epidemiology of AMR and MDR in Staphylococcus infections in
horses whose samples were submitted to the UKVDL.
This information will be useful for guiding future
primary base studies as well as efforts to address the
problem. It is clear that equine Staphylococcus infections
are exhibiting both AMR and MDR in horses. Factors
such as breed and year are significant predictors of the
odds of both AMR and MDR in this study, while species
of staphylococci is also an important predictor of AMR
and age of the horse was significantly associated with
MDR. High levels of AMR and MDR could be indicative
of problems in clinical prescription practices and procedures leading to selection for antimicrobial resistance.
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This highlights the need for a more comprehensive approach to investigating the epidemiology of AMR and
MDR in horses. Future studies will need to focus on improving our understanding of antimicrobial use in horses
as this will allow for more informed antimicrobial stewardship programs. Moreover, AMR surveillance in horses
needs to include better record keeping and lab submission
information (such as pre-treatment history). More information on risk factors may be gained through primary
base observational studies that can more robustly identify
risk factors that might otherwise not be investigated by
retrospective lab-based studies.
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